Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2004-06-28 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75020), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE SAINT-FARGEAU : revenue, balance sheet and financial ratios
SELARL PHARMACIE SAINT-FARGEAU is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75020),
this company of category PME
shows in 2022 a revenue of 8.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE SAINT-FARGEAU (SIREN 478004609)
Indicator
2024
2023
2022
2021
2019
2018
2017
2016
Revenue
N/C
N/C
8 010 184 €
N/C
N/C
N/C
N/C
N/C
Net income
203 551 €
519 902 €
524 921 €
406 506 €
369 312 €
323 431 €
243 476 €
220 779 €
EBITDA
N/C
N/C
640 705 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.6%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2024 erzielt SELARL PHARMACIE SAINT-FARGEAU ein positives Nettoergebnis von 204 k€. Entwicklung 2016-2024: 221 k€ -> 204 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
203 551 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 401%. Kritische Situation: Die Schulden übersteigen das Eigenkapital erheblich. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 17%. Geringe Autonomie: Das Unternehmen ist stark von externer Finanzierung abhängig.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
400.89%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
16.842%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
Debt ratio
168.341
149.678
92.516
73.609
952.424
494.8
559.794
400.89
Financial autonomy
32.221
34.071
43.244
48.966
8.351
14.358
13.047
16.842
Repayment capacity
None
None
None
None
None
12.586
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
5.76%
None%
None%
Sector positioning
Verschuldungsgrad
400.892024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
Im Jahr 2024 liegt über dem Median der Branche das verschuldungsgrad von SELARL PHARMACIE SAINT-FA... (400.89). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Finanzielle Autonomie
16.84%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Beobachten
Im Jahr 2024 liegt in den unteren 25% der Branche das finanzielle autonomie von SELARL PHARMACIE SAINT-FA... (16.8%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Geringe Autonomie kann die Investitionsfähigkeit einschränken und die Verwundbarkeit erhöhen.
Rückzahlungsfähigkeit
12.59 ans2022
2022
Q1: 1.29 ans
Med: 3.55 ans
Q3: 6.63 ans
Average
Im Jahr 2022 liegt über dem Median der Branche das rückzahlungsfähigkeit von SELARL PHARMACIE SAINT-FA... (12.6 ans). Dieses Verhältnis gibt die Anzahl der Jahre an, die zur Rückzahlung der Schulden mit dem Cashflow benötigt werden. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Liquidity ratios
Die Liquiditätsquote beträgt 113.12. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
Liquidity ratio
130.215
109.541
110.206
122.061
205.794
163.591
172.803
113.125
Interest coverage
None
None
None
None
None
10.679
None
None
Sector positioning
Liquiditätsquote
113.122024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Beobachten-11 pts over 3 years
Im Jahr 2024 liegt in den unteren 25% der Branche das liquiditätsquote von SELARL PHARMACIE SAINT-FA... (113.12). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.
Zinsdeckung
10.68x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Ausgezeichnet
Im Jahr 2022 liegt in den oberen 25% der Branche das zinsdeckung von SELARL PHARMACIE SAINT-FA... (10.7x). Dieses Verhältnis gibt an, wie oft das Betriebsergebnis die Zinsaufwendungen deckt. Hohe Deckung bedeutet, dass Finanzaufwendungen die Rentabilität wenig belasten.
Working capital requirement (WCR) and payment terms
Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE SAINT-FARGEAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
636 329 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
30
0
0
Customer payment term (days)
0
0
0
0
0
7
0
0
Supplier payment term (days)
0
0
0
0
0
52
0
0
Positioning of SELARL PHARMACIE SAINT-FARGEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE SAINT-FARGEAU is estimated at
2 841 722 €
(range 1 978 930€ - 4 251 379€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1978k€2841k€4251k€
2 841 722 €Range: 1 978 930€ - 4 251 379€
NAF 5 année 2024
Valuation method used
Net Income Multiple
203 551 €
×
14.0x
=2 841 722 €
Range: 1 978 931€ - 4 251 379€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE SAINT-FARGEAU with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE SAINT-FARGEAU
What is the revenue of SELARL PHARMACIE SAINT-FARGEAU ?
The revenue of SELARL PHARMACIE SAINT-FARGEAU in 2022 is 8.0 M€.
Is SELARL PHARMACIE SAINT-FARGEAU profitable?
Yes, SELARL PHARMACIE SAINT-FARGEAU generated a net profit of 204 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE SAINT-FARGEAU ?
The headquarters of SELARL PHARMACIE SAINT-FARGEAU is located in PARIS (75020), in the department Paris.
Where to find the tax return of SELARL PHARMACIE SAINT-FARGEAU ?
The tax return of SELARL PHARMACIE SAINT-FARGEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE SAINT-FARGEAU operate?
SELARL PHARMACIE SAINT-FARGEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart